News Image

Artivion Announces Presentation of Late-Breaking Clinical Data at the 38th European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting

Provided By PR Newswire

Last update: Oct 10, 2024

5-Year Data from the AMDS DARTS Trial Demonstrates Positive Aortic Remodeling with 94% of Patients Free from Unanticipated Reoperation

30-Day Data from the AMDS PERSEVERE Trial Shows Cerebral Malperfusion Resolution in 90% of Affected Subjects Post-AMDS Implantation

Read more at prnewswire.com

ARTIVION INC

NYSE:AORT (3/7/2025, 8:05:06 PM)

After market: 24.18 0 (0%)

24.18

-0.53 (-2.14%)



Find more stocks in the Stock Screener

Follow ChartMill for more